BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Nordic AML Group - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Nordic AML Group
X-ORIGINAL-URL:https://www.namlg.org
X-WR-CALDESC:Events for Nordic AML Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250911
DTEND;VALUE=DATE:20250913
DTSTAMP:20260430T172547
CREATED:20240425T112440Z
LAST-MODIFIED:20240425T112440Z
UID:10000013-1757548800-1757721599@www.namlg.org
SUMMARY:Nordic AML Meeting 11-12 September 2025
DESCRIPTION:Save the dates for the upcoming Nordic AML Meeting in Bergen\, Norway\, 2025.
URL:https://www.namlg.org/event/nordic-aml-meeting-11-12-september-2025/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251217T150000
DTEND;TZID=Europe/Paris:20251217T170000
DTSTAMP:20260430T172547
CREATED:20251205T081747Z
LAST-MODIFIED:20251205T082100Z
UID:10000031-1765983600-1765990800@www.namlg.org
SUMMARY:Personalized Medicine in the Treatment of AML
DESCRIPTION:Jazz Pharmaceuticals is pleased to invite hematologists from the Nordic AML Group to join a distinguished academic webinar featuring Prof. Dr. med. Lars Bullinger and Prof. Bjørn Tore Gjertsen\, two leading experts in hematology and leukemia research. \nFind more info using this link. \nRegister using this QR code
URL:https://www.namlg.org/event/personalized-medicine-in-the-treatment-of-aml/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260113T160000
DTEND;TZID=Europe/Paris:20260113T170000
DTSTAMP:20260430T172547
CREATED:20251128T073938Z
LAST-MODIFIED:20251128T073938Z
UID:10000029-1768320000-1768323600@www.namlg.org
SUMMARY:NAMLG - Steering group meeting
DESCRIPTION:Agenda and meeting link will be sent via e-mail.
URL:https://www.namlg.org/event/namlg-steering-group-meeting/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260120T150000
DTEND;TZID=Europe/Paris:20260120T190000
DTSTAMP:20260430T172547
CREATED:20260108T182048Z
LAST-MODIFIED:20260108T182048Z
UID:10000032-1768921200-1768935600@www.namlg.org
SUMMARY:Best of ASH 2025 by Lund
DESCRIPTION:At Best of ASH 2025\, hematologists in Lund\, Sweden present their top picks from the annual meeting of the American Society of Hematology (ASH) cutting through the volume to focus on data that change how we treat patients. Expect concise\, expert-led updates on key trials\, late-breaking abstracts\, and their real-world implications across hematology. \nLive on YouTube: https://www.youtube.com/live/DJrW-8hEHvI
URL:https://www.namlg.org/event/best-of-ash-2025-by-lund/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260226T140000
DTEND;TZID=Europe/Paris:20260226T151500
DTSTAMP:20260430T172547
CREATED:20260123T135454Z
LAST-MODIFIED:20260123T144130Z
UID:10000033-1772114400-1772118900@www.namlg.org
SUMMARY:Webinar - Innovations in AML care: Integrating Novel Treatments into Nordic Practice
DESCRIPTION:The Nordic AML Group’s Educational Working Group invites you to a scientific webinar focusing on recent innovations in the treatment of AML and their implementation in Nordic clinical practice. \nThe webinar will feature three expert speakers covering: \n– The evolving AML treatment landscape by professor Gail Roboz (New York) \n– Early Nordic experience with new AML therapies and ongoing Nordic studies by professor Bjørn Tore Gjertsen (Bergen) \n– Access pathways and future developments in AML care by associate professor Anne Louise Tølbøll Sørensen (Copenhagen) \nAim: To provide a clinically relevant and up-to-date overview of emerging therapeutic approaches for AML\, with particular emphasis on feasibility\, relevance\, and early adoption within the Nordic region. \nFormat: Webinar via Zoom via this link \nSponsorship: Sponsored by Otsuka. The sponsor has no influence on the scientific content or agenda. \n################################# \nAgenda – 2026-02-26 – 14:00 – 15:15 (CET) \n14:00 – 14:05 – Welcome & Introduction \n14:05 – 14:20 – The Evolving AML Landscape\, Professor Gail Roboz (New York) \n14:20 – 14:35 – From Data to Practice: Early Nordic Experience with New AML Treatments\, Professor Bjørn Tore Gjertsen (Bergen) \n14:35 – 14:45 – Discussion \n14:45 – 15:00 – Ongoing Nordic Studies\, Access Pathways\, and What’s Coming Next\, Associate professor Anne Louise Tølbøll Sørensen (Copenhagen) \n15:00 – 15:10 – Discussion \n15:10 – 15:15 – Closing remarks \n################################# \n 
URL:https://www.namlg.org/event/webinar-innovations-in-aml-care/
LOCATION:https://www.namlg.org/event/webinar-innovations-in-aml-care/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260303T160000
DTEND;TZID=Europe/Paris:20260303T170000
DTSTAMP:20260430T172547
CREATED:20251128T074113Z
LAST-MODIFIED:20251128T074113Z
UID:10000030-1772553600-1772557200@www.namlg.org
SUMMARY:NAMLG – Steering group meeting
DESCRIPTION:Agenda and meeting link will be sent via e-mail.
URL:https://www.namlg.org/event/namlg-steering-group-meeting-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260305T150000
DTEND;TZID=Europe/Paris:20260305T160000
DTSTAMP:20260430T172547
CREATED:20260304T002545Z
LAST-MODIFIED:20260304T002615Z
UID:10000036-1772722800-1772726400@www.namlg.org
SUMMARY:Germline Predisposition to Myeloid Neoplasms - Case discussions
DESCRIPTION:Join the MDR for patients with germline predisposition for hematological malignancies. \nThis meeting is for clinicians within the Nordics via this Zoom-link. \nIf you want to discuss a case\,  please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se)\, Uppsala\, Sweden. \n 
URL:https://www.namlg.org/event/germline-predisposition-to-myeloid-neoplasms-case-discussions/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260317T170000
DTEND;TZID=Europe/Paris:20260317T180000
DTSTAMP:20260430T172547
CREATED:20260216T121257Z
LAST-MODIFIED:20260216T121257Z
UID:10000035-1773766800-1773770400@www.namlg.org
SUMMARY:Webinar - Ask the expert: FLT3 MRD testing in AML patients
DESCRIPTION:Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis\, MD\, PhD\, Baltimore\, USA\, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda: \nAssess the current minimal residual disease testing modalities/methods\n Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities\n Summarize the appropriate treatment strategies in a post-transplant setting\n Best practice sharing in developing/setting up FLT3 MRD testing \nMore info and register here.
URL:https://www.namlg.org/event/webinar-ask-the-expert-flt3-mrd-testing-in-aml-patients/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260507T150000
DTEND;TZID=Europe/Paris:20260507T160000
DTSTAMP:20260430T172547
CREATED:20260304T002832Z
LAST-MODIFIED:20260304T002832Z
UID:10000037-1778166000-1778169600@www.namlg.org
SUMMARY:Germline Predisposition to Myeloid Neoplasms – Case discussions
DESCRIPTION:Join the MDR for patients with germline predisposition for hematological malignancies. \nThis meeting is for clinicians within the Nordics.via this Zoom-link. \nIf you want to discuss a case\,  please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se)\, Uppsala\, Sweden.
URL:https://www.namlg.org/event/germline-predisposition-to-myeloid-neoplasms-case-discussions-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260613T003000
DTEND;TZID=Europe/Paris:20260613T140000
DTSTAMP:20260430T172547
CREATED:20250917T130048Z
LAST-MODIFIED:20250917T130048Z
UID:10000028-1781310600-1781359200@www.namlg.org
SUMMARY:NAMLG meeting @ EHA2026
DESCRIPTION:
URL:https://www.namlg.org/event/namlg-meeting-eha2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260916T080000
DTEND;TZID=Europe/Paris:20260916T170000
DTSTAMP:20260430T172547
CREATED:20250917T125837Z
LAST-MODIFIED:20250917T125941Z
UID:10000026-1789545600-1789578000@www.namlg.org
SUMMARY:AML Course Day 2026 - Bergen
DESCRIPTION:
URL:https://www.namlg.org/event/aml-course-day-bergen/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260917
DTEND;VALUE=DATE:20260919
DTSTAMP:20260430T172547
CREATED:20250917T125923Z
LAST-MODIFIED:20250917T125923Z
UID:10000027-1789603200-1789775999@www.namlg.org
SUMMARY:Nordic AML Meeting 2026 - Bergen
DESCRIPTION:
URL:https://www.namlg.org/event/nordic-aml-meeting-2026-bergen/
END:VEVENT
END:VCALENDAR